Showing results (801-810 of 839) with videos related to

Sort By:
Pageof 84
Marine Pollution Bulletin|September 8, 2015
Baseline survey of marine sediments collected from the State of Kuwait: PAHs, PCBs, brominated flame retardants and metal contaminationB P Lyons, J L Barber, H S Rumney, et al.
The Journal of Clinical Investigation|October 24, 2023
Activation of mTOR signaling in adult lung microvascular progenitor cells accelerates lung agingEmma C Mason, Swapna Menon, Benjamin R Schneider, et al.
Journal of the National Cancer Institute|January 3, 1996
Phase II trial of interleukin 1 alpha and indomethacin in treatment of metastatic melanomaJ E Janik, L L Miller, D L Longo, et al.
Brain Communications|July 11, 2022
Vessel wall magnetic resonance and arterial spin labelling imaging in the management of presumed inflammatory intracranial arterial vasculopathyL A Benjamin, E Lim, M Sokolska, et al.
Nucleic Acids Research|October 9, 2010
The IKMC web portal: a central point of entry to data and resources from the International Knockout Mouse ConsortiumMartin Ringwald, Vivek Iyer, Jeremy C Mason, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinomaR G Fenton, R G Steis, K Madara, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 1, 2017
A comparison of the left thoracoabdominal and Ivor-Lewis esophagectomyA R Davies, J Zylstra, C R Baker, et al.
Science (New York, N.Y.)|November 16, 2023
Nickel-catalyzed ester carbonylation promoted by imidazole-derived carbenes and saltsChangho Yoo, Shrabanti Bhattacharya, Xin Yi See, et al.
Bone Marrow Transplantation|February 10, 2004
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphomaG L Phillips, B R Meisenberg, D E Reece, et al.
Leukemia|July 24, 2015
β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemiaA M Eiring, J S Khorashad, D J Anderson, et al.
Pageof 84